What is the recommended oral fosfomycin (fosfomycin tromethamine) dose for adults and children with uncomplicated urinary tract infection, and how should the dose be adjusted in renal impairment?

Fosfomycin Oral Dose for Uncomplicated UTI

For adults with uncomplicated urinary tract infection (acute cystitis), the recommended dose is fosfomycin tromethamine 3 grams as a single oral dose. 1

Adult Dosing

Standard Dose

• Fosfomycin tromethamine 3 grams orally as a single dose for uncomplicated cystitis in women 2, 3, 2, 1
• Must be mixed with water before ingesting; never take in dry form 1
• Can be taken with or without food 1

Clinical Context

The 2024 European Association of Urology guidelines list fosfomycin trometamol 3g single dose as first-line therapy for uncomplicated cystitis in women 2. However, the 2024 WHO guidelines notably excluded fosfomycin from their recommendations based on evidence showing nitrofurantoin achieved significantly greater clinical and microbiologic resolution at 28 days compared to single-dose fosfomycin 4. A 2026 randomized trial (SCOUT) confirmed this, showing fosfomycin had the lowest clinical resolution rate (59%) compared to nitrofurantoin (74%) 5.

Important caveat: Fosfomycin is recommended only for uncomplicated cystitis in women, not for pyelonephritis or complicated UTIs, as it does not achieve adequate tissue concentrations outside the urinary tract 6, 3.

Pediatric Dosing

For children with uncomplicated UTI, a single dose of 2 grams of fosfomycin trometamol has been studied 7, though pediatric guidelines do not routinely recommend fosfomycin as first-line therapy. The 2011 AAP guideline for febrile infants 2-24 months does not include fosfomycin in recommended regimens 6.

Renal Impairment Dosing

No specific dose adjustment is provided in the FDA label for renal impairment 1. However, critical pharmacokinetic considerations apply:

• In patients with creatinine clearance <50 mL/min, the half-life increases significantly (from 11 hours to 50 hours) 1, 8
• Urinary excretion decreases from 32% to 11% in severe renal impairment 1
• In anuric patients on hemodialysis, the half-life extends to 40 hours 1
• Dose modification is necessary when creatinine clearance is below 50 mL/min 8

Clinical approach: While the standard 3-gram single dose remains the labeled dose, clinicians should exercise caution in moderate-to-severe renal impairment given reduced urinary excretion and prolonged half-life. Consider alternative agents with better-established dosing in renal dysfunction.

Special Populations

Pregnancy

• Classified as pregnancy category B 9
• Crosses the placental barrier 1
• Considered safe for use during pregnancy 10

Elderly

• No dosage adjustment necessary in elderly patients 1, 11
• No differences in urinary excretion observed 1

Multidrug-Resistant Organisms

For vancomycin-resistant enterococci (VRE) causing uncomplicated UTI, the 2022 Taiwan guidelines recommend a single dose of fosfomycin 3g PO 12. This represents an important niche indication where fosfomycin's activity against resistant organisms is valuable.

Key Pharmacokinetic Points

• Peak urinary concentrations of 706-4415 mg/L occur within 2-4 hours 1, 9
• Urinary concentrations remain >100 mg/L for 24-48 hours after a single dose 1, 9
• Oral bioavailability is 37% fasting, reduced to 30% with food 1
• Not metabolized; excreted unchanged in urine (38%) and feces (18%) 1

Common Pitfalls

1. Do not use for pyelonephritis: Fosfomycin does not achieve adequate serum/tissue concentrations for upper tract infections 6, 3
2. Avoid metoclopramide co-administration: Significantly lowers serum concentrations and urinary excretion 1
3. Not for men: Most guidelines restrict fosfomycin to women with uncomplicated cystitis 2
4. Inferior efficacy: Recent high-quality evidence shows lower cure rates compared to nitrofurantoin 4, 5